Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: economics
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
Showing
1
-
20
of
346
Search:
'economics'
,
query time: 0.02s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Clinical and
economic
review report: Infliximab SC (Remsima) : Celltrion Healthcare Co., Ltd. : indication : rheumatoid arthritis
Published 2021
Canadian Agency for Drugs and Technologies in Health
“
...Clinical and
economic
review report for infliximab (Remsima)...
”
Read Now
2
Clinical and
economic
review report: Vedolizumab (ENTYVIO SC) Takeda Canada Inc. : indication: Crohn disease
Published 2021
Canadian Agency for Drugs and Technologies in Health
“
...CADTH common drug review Clinical and
economic
review report for Vedolizumab (Entyvio SC)...
”
Read Now
3
Axicabtagene ciloleucel for diffuse large B-cell lymphoma:
Economic
review report
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
...
Economic
review report...
”
Read Now
4
Axicabtagene ciloleucel for diffuse large B-cell lymphoma:
Economic
review report
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antigens, CD19 /
economics
...
”
Read Now
5
Direct oral anticoagulants for the treatment of venous thromboembolic events : economic evaluation
by
Klarenbach, Scott
Published 2016
CADTH
Subjects:
“
...Anticoagulants /
economics
...
”
Read Now
6
Direct oral anticoagulants for the treatment of venous thromboembolic events : economic evaluation
by
Klarenbach, Scott
Published 2016
CADTH
“
... includes both a clinical and an
economic
evaluation. The clinical component was conducted by ccNMA...
”
Read Now
7
Vancomycin or metronidazole for treatment of Clostridium difficile infection : clinical and economic analyses
by
Perras, Christine
Published 2011
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Vancomycin /
economics
...
”
Read Now
8
Vancomycin or metronidazole for treatment of Clostridium difficile infection : clinical and economic analyses
by
Perras, Christine
Published 2011
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Vancomycin /
economics
...
”
Read Now
9
CADTH Canadian Drug Expert Committee recommendation: Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide (Symtuza -- Janssen Inc.) : indication: treatment of HIV type 1 (HIV-1...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cobicistat /
economics
...
”
Read Now
10
Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and
economic
impact of standard versus extended duration
by
Wells, George A.
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Drug Therapy, Combination /
economics
...
”
Read Now
11
Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and
economic
impact of standard versus extended duration : recommendations
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Drug Therapy, Combination /
economics
...
”
Read Now
12
Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and
economic
impact of standard versus extended duration : project protocol
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
...Clinical and
economic
impact of standard versus extended duration...
”
Read Now
13
Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and
economic
impact of standard versus extended duration
by
Wells, George A.
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
...Clinical and
economic
impact of standard versus extended duration...
”
Read Now
14
Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and
economic
impact of standard versus extended duration : recommendations
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Drug Therapy, Combination /
economics
...
”
Read Now
15
Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and
economic
impact of standard versus extended duration : project protocol
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Drug Therapy, Combination /
economics
...
”
Read Now
16
Pharmacoeconomic review report: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antiviral Agents /
economics
...
”
Read Now
17
Pharmacoeconomic review report: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antiviral Agents /
economics
...
”
Read Now
18
Antibiotic impregnated cement for primary hip or knee arthroplasty : a review of the clinical and cost-effectiveness
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Arthroplasty, Replacement, Hip /
economics
...
”
Read Now
19
Costs of contact tracing activities aimed at reducing the transmission of measles in Canada
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Contact Tracing /
economics
...
”
Read Now
20
Non-invasive prenatal testing : a review of the cost effectiveness and guidelines
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-Benefit Analysis /
economics
...
”
1
2
3
4
5
6
7
8
9
10
11
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Year of Publication
From:
To:
Classification
330 - Economics
274
610 - Medicine & health
157
140 - Specific philosophical schools
25
700 - The arts; fine & decorative arts
19
800 - Literature & rhetoric
5
580 - Plants (Botany)
4
more ...
600 - Technology
4
615 - Pharmacology & therapeutics
2
100 - Philosophy & psychology
1
363 - Other social problems & services
1
see all ...
less ...
Language
English
346
Collection
National Center for Biotechnology Information
346
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
58
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
34
Ho, Chuong
14
Adcock, Lorna
7
Grobelna, Aleksandra
7
more ...
Ford, Caitlyn
6
Assasi, Nazila
5
McCormack, Suzanne
5
Argáez, Charlene
4
Chao, Yi-Sheng
4
Gray, Casey
4
Poitras, Veronica
4
Tran, Khai
4
Banerjee, Srabani
3
Campbell, Kaitryn
3
Chiu, Stephanie
3
Frey, Nina
3
Klarenbach, Scott
3
Lee, Karen M.
3
Loshak, Hannah
3
MacDougall, Danielle
3
Wells, Charlotte
3
Wells, George A.
3
Williams, D.
3
Young, Calvin
3
Farrah, Kelly
2
Jahagirdar, Deepa
2
Kanga, Ismat
2
Kim, Joanne
2
Perras, Christine
2
Spry, Carolyn
2
Visintini, Sarah
2
Adams, Alison
1
Clark, Michelle
1
Cowling, Tara
1
De Nanassy, Alina
1
Edge, Rob
1
Harricharan, Sharada
1
Khangura, Sara
1
Krahn, Murray
1
La Fleur, Philip
1
Lachance, Chantelle
1
Manns, Braden
1
Marchand, Dave K.
1
McIntosh, Brendan
1
Membe, Stephen K.
1
Narain, Tasha
1
Palylyk-Colwell, Eugenia
1
Picheca, Lory
1
Singh, Sumeet
1
So, Helen
1
Subramonian, Anusree
1
Thompson, Wade
1
Tonelli, Marcello
1
Wong, William
1
Wright, Mary-Doug
1
Yeung, Shirley S. T.
1
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&lookfor=economics&type=AllFields
Send by Email
×
Loading...